RHOC and breast cancer: Overexpression of wildtype RhoC in vitro drives invasion of HME and MCF10A cells in both 2D and 3D culture [10, 11], and high levels of RhoC observed in the SUM149 inflammatory breast cancer cell line are thought to increase production of pro-angiogenic factors [11].